Financial News
Sarepta Therapeutics (NQ: SRPT )
140.56
-0.87
(-0.62%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Headline News about Sarepta Therapeutics
![](https://cdn.benzinga.com/files/images/story/2023/03/17/image19.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/17/share_market_photo_by_phongphan_on_shutterstock.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](/next-assets/images/schema-image-default.png)
10 Health Care Stocks Whale Activity In Today's Session
March 16, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4352.jpeg?width=1200&height=800&fit=crop)
The Latest Analyst Ratings for Sarepta Therapeutics
March 03, 2023
Via Benzinga
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
![](https://investorplace.com/wp-content/uploads/2022/06/biotechnologyepzm1600.png)
![](https://cdn.benzinga.com/files/images/story/2023/03/09/image-meta-facebook.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://g.foolcdn.com/editorial/images/723360/doctor-holding-elderly-patients-hand.jpg)
![](https://www.investors.com/wp-content/uploads/2019/08/stock-bounce-back-01-adobe.jpg)
![](/next-assets/images/schema-image-default.png)
Expert Ratings for Sarepta Therapeutics
February 15, 2023
Via Benzinga
![](https://g.foolcdn.com/editorial/images/723172/scientist-altering-dna-genome-project-1.jpg)
![](https://g.foolcdn.com/editorial/images/722910/wooden-cube-blocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/stock_chart_rising.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/sarepta_columbus_0631-web.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image_6_0.jpg?width=1200&height=800&fit=crop)
9 Analysts Have This to Say About Sarepta Therapeutics
January 20, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image14.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/09/Stock-Sarepta-Boston01-company.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2019/12/srpt-stock.jpg)
![](https://g.foolcdn.com/editorial/images/722915/biotech-scientist-microscope-getty.jpg)
![](/next-assets/images/schema-image-default.png)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image-sarepta_therapeutics.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image12.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2021/04/wall-street-washington-statue.jpg)
![](https://g.foolcdn.com/editorial/images/1/featured-transcript-logo-template-2023-01-12.jpg)
![](/next-assets/images/schema-image-default.png)
12 Health Care Stocks Moving In Tuesday's After-Market Session
February 28, 2023
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2020/03/gene_editing_a_1600.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.